SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | n/a |
Enterprise Value ($M) | n/a |
Book Value ($M) | n/a |
Book Value / Share | n/a |
Price / Book | n/a |
NCAV ($M) | 0.00 |
NCAV / Share | n/a |
Price / NCAV | n/a |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | n/a |
Return on Assets (ROA) | n/a |
Return on Equity (ROE) | n/a |
Liquidity (mrq) | |
---|---|
Quick Ratio | n/a |
Current Ratio | n/a |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | n/a |
Assets | n/a |
Liabilities | n/a |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | n/a |
Operating Income | n/a |
Net Income | n/a |
Earnings Per Share Basic And Diluted | n/a |
Earnings Per Share Diluted | n/a |
Earnings Per Share Basic | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | n/a |
Cash from Investing | n/a |
Cash from Financing | n/a |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | Stonepine Capital Management, LLC | 0.00 | -100.00 | |
13G/A | Boothbay Fund Management, Llc | 0.00 | -100.00 | |
13D/A | Caligan Partners LP | 0.00 | -100.00 | |
13D/A | Velan Capital Investment Management LP | 0.00 | -100.00 | |
13G/A | Lytton Laurence W | 4.20 | -26.78 | |
13G/A | HBM Healthcare Investments (Cayman) Ltd. | 0.90 | 0.00 | |
13G/A | Altium Capital Management LP | 5.00 | -10.88 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
Similar Companies | |
---|---|
ACET – Adicet Bio, Inc. | ACIU – AC Immune SA |
ACRV – Acrivon Therapeutics, Inc. | ADMA – ADMA Biologics, Inc. |
AFMD – Affimed N.V. |